Newpath Partners

Portfolio Co Investors 2026 for Newpath Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Newpath Partners accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.3B. The median disclosed raise is $103M, and the largest is Neumora Therapeutics at $500M, ahead of Orbital Therapeutics ($270M) and Myeloid Therapeutics ($195M).

The names that recur most often on these co-invested cap tables are Newpath Partners (8 companies), ARCH Venture Partners (5 companies), Alexandria Venture Investments (3 companies), F-Prime Capital (3 companies), Mubadala Capital (2 companies), Polaris Partners (2 companies). By latest disclosed round, the market skews Series A (5), Series B (2), Seed (1).

Companies tracked: 8
Disclosed funding total: $1.3B across 8 companies
Median disclosed raise: $103M
Largest raise: Neumora Therapeutics — $500M
Stage mix: Series A 5 · Series B 2 · Seed 1
Most recent dated round: 2026-05-14

Newpath Partners GP III, L.P. — related firms and companies (56)

Newpath Partners GP III, L.P. profile · All research reports

Newpath Partners

Best funded Newpath Partners companies

Newpath Partners GP III, L.P. — related firms and companies (56)